CASE STUDY
Title
Case Information (Patient History)
Definition of Disease
Other Name
Risk Factors
Predisposing Factors
Etiology
Anatomy and Physiology
Pathology (Pathogenesis, Pathophysiology)
Clinical Manifestations with Rationale
Diagnostic Evaluation/Examination and Laboratories
Nursing Care Plan
Assessment
Diagnosis
Inference
Planning
Intervention with Rationale
Evaluation
Drug Study
Discharge Plan
Case Study: Pneumonia
Definition of Disease
Pneumonia is an acute or chronic infection of the lung parenchyma characterized by
inflammation of the alveoli, interstitial tissue, and/or bronchioles, leading to impaired gas
exchange. It can be caused by bacteria, viruses, fungi, or aspiration of foreign substances.
Other Name
• Lung infection
• Pulmonary infection
• Lower respiratory tract infection (LRTI)
Risk Factors
• Extremes of age (infants and elderly)
• Smoking
• Chronic illnesses (COPD, asthma, diabetes mellitus, heart failure)
• Immunosuppression (HIV, cancer, chemotherapy, long-term steroid use)
• Malnutrition
• Recent viral respiratory infection (e.g., influenza, COVID-19)
• Prolonged hospitalization or mechanical ventilation
Predisposing Factors
• Poor socioeconomic status and overcrowding
• Poor oral hygiene
• Alcoholism and substance abuse
• Exposure to environmental pollutants or occupational irritants
• Gastroesophageal reflux disease (GERD) increasing risk of aspiration
• Bedridden state or immobility
• Incomplete immunization (e.g., pneumococcal, influenza vaccine)
Etiology
Pneumonia can be classified based on its causative agents and setting of acquisition:
• Bacterial: Streptococcus pneumoniae (most common), Haemophilus influenzae,
Klebsiella pneumoniae, Staphylococcus aureus, atypical bacteria (Mycoplasma
pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila).
• Viral: Influenza virus, respiratory syncytial virus (RSV), SARS-CoV-2, adenovirus.
• Fungal: Histoplasma capsulatum, Coccidioides immitis, Candida species (common in
immunocompromised).
• Aspiration: Entry of gastric contents, oral secretions, or foreign materials into lungs.
• Hospital-acquired: Multidrug-resistant organisms like Pseudomonas aeruginosa and
MRSA.
Anatomy and Physiology
The respiratory system consists of:
• Upper respiratory tract (nasal cavity, pharynx, larynx) – filters and humidifies air.
• Lower respiratory tract (trachea, bronchi, bronchioles, alveoli) – responsible for gas
exchange.
• Alveoli are the functional units of the lungs where oxygen diffuses into the blood and
carbon dioxide is removed.
Normal defense mechanisms include mucociliary clearance, alveolar macrophages, cough reflex,
and immune responses that protect the lungs from pathogens.
Pathology
Pathogenesis / Pathophysiology
1. Inhalation/aspiration/hematogenous spread introduces pathogens into the alveoli.
2. Inflammatory response: Neutrophils, macrophages, and cytokines are activated, leading
to alveolar-capillary membrane damage.
3. Alveolar filling: Alveoli fill with exudate (fluid, pus, bacteria, and immune cells),
impairing oxygen-carbon dioxide exchange.
4. Consolidation: Lung tissue becomes firm and airless due to accumulation of exudate.
5. Resolution/complications: With treatment, exudate is resorbed; without treatment,
complications like abscess, pleural effusion, or sepsis may develop.
Clinical Manifestations with Rationale
Clinical Manifestation Rationale
Inflammatory response stimulates cough reflex to expel
Cough (productive or dry)
secretions.
Release of pyrogens and cytokines increases body
Fever and chills
temperature.
Alveolar exudate reduces oxygen exchange, causing
Dyspnea / shortness of breath
hypoxemia.
Inflammation of pleura irritates nerve endings, producing
Chest pain (pleuritic)
sharp pain.
Compensatory response to hypoxemia and increased
Tachypnea and tachycardia
metabolic demands.
Crackles, rales, or bronchial Air passing through fluid-filled alveoli produces abnormal
breath sounds sounds.
Severe hypoxemia results in bluish discoloration of skin
Cyanosis
and mucous membranes.
Systemic effect of infection and poor oxygen delivery to
Fatigue, malaise, weakness
tissues.
Confusion (especially in elderly) Reduced cerebral oxygenation due to hypoxemia.
Diagnostic Evaluation / Examination and Laboratories
1. History and Physical Examination – cough, fever, dyspnea, auscultation of lungs.
2. Chest X-ray – shows consolidation, infiltrates, or patchy opacities.
3. Sputum Gram stain and culture – identifies causative organism.
4. Complete blood count (CBC) – leukocytosis with left shift in bacterial pneumonia;
normal/low WBC in viral or immunocompromised.
5. Pulse oximetry / Arterial Blood Gas (ABG) – detects hypoxemia and acid-base
imbalance.
6. Blood cultures – to rule out bacteremia/sepsis.
7. C-reactive protein (CRP), Procalcitonin – elevated in bacterial infections, useful for
monitoring response to therapy.
8. CT scan of chest (if needed) – more detailed imaging for complications or unclear cases.
Management
Medical Management
• Antibiotic Therapy (for bacterial pneumonia)
o Empiric therapy based on most likely organism (e.g., amoxicillin, macrolides,
fluoroquinolones, or broad-spectrum antibiotics for hospital-acquired cases).
o Adjust according to culture and sensitivity results.
• Antiviral Therapy (for viral pneumonia)
o Oseltamivir or zanamivir for influenza pneumonia.
• Antifungal Therapy (for fungal pneumonia in immunocompromised patients).
• Supportive Therapy
o Oxygen therapy to correct hypoxemia.
o Intravenous fluids for hydration.
o Antipyretics (paracetamol) for fever.
o Analgesics for chest pain.
o Bronchodilators (if associated with bronchospasm).
Midwifery Management
Midwifery Assessment:
• Monitor vital signs, especially temperature, respiratory rate, and oxygen saturation.
• Assess breath sounds and note changes (crackles, wheezes, diminished sounds).
• Monitor for signs of hypoxemia (restlessness, confusion, cyanosis).
• Assess sputum characteristics (color, amount, odor).
Midwifery Diagnoses (examples):
1. Impaired gas exchange related to alveolar-capillary membrane changes.
2. Ineffective airway clearance related to increased secretions.
3. Activity intolerance related to imbalance between oxygen supply and demand.
4. Risk for infection transmission related to presence of causative pathogen.
Midwifery Interventions:
• Position patient in semi-Fowler’s to promote lung expansion.
• Encourage deep breathing, coughing, and incentive spirometry.
• Provide oxygen therapy as prescribed.
• Administer medications (antibiotics, bronchodilators, mucolytics) as ordered.
• Maintain adequate hydration (2–3 L/day if not contraindicated) to thin secretions.
• Educate patient and family on completing antibiotic course, hand hygiene, and
vaccination (influenza, pneumococcal).
• Provide rest periods and cluster nursing care to avoid fatigue.
Evaluation:
• Patient maintains oxygen saturation > 95% (or baseline).
• Resolution of fever and infection signs.
• Clear breath sounds and improved lung expansion.
• Patient demonstrates understanding of prevention strategies.
Pharmacological Management
• First-line antibiotics (community-acquired pneumonia, outpatient):
o Amoxicillin, macrolides (azithromycin, clarithromycin), doxycycline.
• Hospital-acquired pneumonia (HAP):
o Broad-spectrum antibiotics (piperacillin-tazobactam, cefepime, meropenem) +
MRSA coverage if needed (vancomycin, linezolid).
• Antiviral agents: oseltamivir, zanamivir (for influenza).
• Antipyretics/analgesics: paracetamol, ibuprofen.
• Mucolytics/expectorants: ambroxol, guaifenesin.
• Bronchodilators: salbutamol (if bronchospasm present).
Complications
• Respiratory failure due to severe hypoxemia.
• Pleural effusion (fluid accumulation in pleural space).
• Lung abscess (localized pus collection).
• Empyema (infected pleural fluid).
• Sepsis and septic shock.
• Chronic lung disease (in recurrent or poorly treated pneumonia).
Prognosis
• Favorable in young, healthy individuals with prompt treatment.
• Guarded in elderly, immunocompromised, or those with multiple comorbidities.
• Mortality is higher in hospital-acquired pneumonia and in cases leading to sepsis or
multi-organ failure.
• Vaccination and preventive strategies significantly reduce recurrence and severity.
Midwifery Care Plan: Pneumonia
Assessment
• Subjective Data:
o Patient complains of shortness of breath, chest pain on inspiration, fever,
productive cough with yellow-green sputum, generalized weakness.
o Reports difficulty sleeping due to cough and breathing problems.
• Objective Data:
o Temperature: 38.7°C
o Respiratory Rate: 28/min (tachypnea)
o Heart Rate: 110 bpm (tachycardia)
o Oxygen saturation: 89% on room air
o Use of accessory muscles in breathing
o Auscultation: crackles/rhonchi on lower lung fields
o Restlessness and fatigue
o CBC: leukocytosis
o Chest X-ray: consolidation on right lower lobe
Diagnosis (NANDA-I Based)
1. Impaired gas exchange related to alveolar-capillary membrane changes as evidenced by
low SpO₂ and dyspnea.
2. Ineffective airway clearance related to excessive secretions as evidenced by productive
cough and abnormal breath sounds.
3. Hyperthermia related to infectious process as evidenced by elevated temperature.
4. Activity intolerance related to imbalance between oxygen supply and demand.
5. Knowledge deficit related to disease condition, treatment regimen, and prevention of
recurrence.
Inference
Pneumonia is a lung infection that leads to inflammation and filling of alveoli with fluid/pus,
impairing oxygen exchange. In pregnant or postpartum women, the increased oxygen demand,
reduced lung capacity, and lowered immunity predispose them to rapid deterioration. This
condition may affect maternal health, fetal oxygenation, and breastfeeding capacity.
Planning (Goals & Objectives)
• Patient will maintain adequate oxygenation with SpO₂ ≥ 95% (or baseline).
• Patient will demonstrate effective airway clearance (clear breath sounds, reduced cough
frequency).
• Patient will maintain normal body temperature (< 37.5°C) within 72 hours of therapy.
• Patient will verbalize increased energy and tolerance for activity.
• Patient and family will demonstrate understanding of treatment regimen, medications,
and preventive measures (vaccination, infection control).
Intervention with Rationale
Intervention Rationale
Promotes lung expansion and eases
Place patient in semi-Fowler’s or high-Fowler’s position.
breathing.
Corrects hypoxemia and improves
Administer oxygen therapy as ordered.
tissue perfusion.
Encourage deep breathing, coughing exercises, and use Mobilizes secretions and prevents
of incentive spirometer. atelectasis.
Perform frequent vital signs and oxygen saturation Early detection of deterioration or
monitoring. complications.
Treats underlying infection,
Administer antibiotics, antipyretics, bronchodilators as
controls fever, and improves
prescribed.
airway patency.
Thins secretions and supports
Provide adequate hydration (oral/IV).
systemic circulation.
Conserves energy and prevents
Encourage rest with gradual activity resumption.
fatigue.
Educate patient and family about disease process,
Prevents recurrence and
importance of completing medications, and vaccination
complications.
(pneumococcal, influenza).
Assess fetal heart rate and maternal well-being (if Ensures fetal oxygenation and
pregnant). maternal stability.
Reduces anxiety, promotes
Provide emotional support and counseling. cooperation, and supports maternal
role.
Evaluation
• Patient’s oxygen saturation maintained at ≥ 95%.
• Patient’s cough productive with thinner secretions; lung sounds clear after expectoration.
• Temperature normalized to 36.5–37.3°C.
• Patient tolerated ambulation without dyspnea or fatigue.
• Patient and family verbalized understanding of medication regimen, infection prevention,
and follow-up care.
Drug Study (Examples)
Generic / Dosag Nursing
Classificatio
Drug Brand e/ Indication Side Effects Responsibili
n
Name Route ty
Assess for
500
allergies,
mg
Amoxicilli monitor
Penicillin PO Bacterial Nausea,
Antibiotic n/ response,
antibiotic q8h x pneumonia diarrhea, rash
Augmentin instruct to
7–10
complete
days
course.
500
mg–1 Monitor
g PO temperature,
Hepatotoxici
Antipyretic/Analge Paracetam Analgesic, q6h avoid
Fever, pain ty (high
sic ol antipyretic PRN overdose,
doses)
(max encourage
4 hydration.
g/day)
Monitor HR
2.5 mg
Salbutamo Bronchospas and RR,
neb Tremors,
Bronchodilator l/ β2-agonist m with teach proper
q4–6h palpitations
Ventolin pneumonia nebulizer
PRN
use.
Encourage
30 mg fluids,
Thick
Mucolytic Ambroxol Expectorant PO GI upset monitor
sputum
TID sputum
consistency.
Discharge Plan
Medications
• Complete full course of antibiotics as prescribed.
• Continue supportive medications (paracetamol, mucolytics, bronchodilators if needed).
Diet
• Balanced diet rich in protein and vitamins (especially Vitamin C) to support healing.
• Increase oral fluid intake (2–3 L/day if not contraindicated) to liquefy secretions.
Activity
• Gradual resumption of daily activities.
• Adequate rest to conserve energy.
• Avoid strenuous activity until fully recovered.
Hygiene & Environment
• Practice proper hand hygiene.
• Avoid exposure to smoke, dust, and pollutants.
• Maintain adequate ventilation at home.
Health Teaching
• Importance of vaccination (influenza, pneumococcal).
• Avoid smoking and alcohol.
• Seek early consultation for fever, cough, or breathing difficulty.
• Educate about warning signs (persistent fever, worsening dyspnea, chest pain, confusion).
Follow-Up
• Return for check-up within 1–2 weeks or earlier if symptoms worsen.
• Chest X-ray and labs may be repeated to confirm resolution.
Referral
• Pulmonology referral if pneumonia is recurrent, severe, or with complications.
• Obstetric referral (if pregnant) for continuous fetal monitoring.